In vivo MRI of hyperpolarized silicon‐29 nanoparticles
Magnetic Resonance in Medicine · 2024
DOI: 10.1002/mrm.30244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Magnetic Resonance in Medicine, 2024. Verfasst von Grzegorz Kwiatkowski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biomedical Engineering, University and ETH Zurich, Switzerland. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Silicon, Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: EU Horizon 2020 FETFLAG MetaboliQs.
Abstract (Originalsprache)
Purpose
The objective of the present work was to test the feasibility of in vivo imaging of hyperpolarized 50‐nm silicon‐29 ( 29 Si) nanoparticles.
Methods
Commercially available, crystalline 50‐nm nanoparticles were hyperpolarized using dynamic polarization transfer via the endogenous silicon oxide–silicon defects without the addition of exogenous radicals. Phantom experiments were used to quantify the effect of sample dissolution and various surface coating on T 1 and T 2 relaxation. The in vivo feasibility of detecting hyperpolarized silicon‐29 was tested following intraperitoneal, intragastric, or intratumoral injection in mice and compared with the results obtained with previously reported, large, micrometer‐size particles. The tissue clearance of SiNPs was quantified in various organs using inductively coupled plasma optical emission spectroscopy.
Results
In vivo images obtained after intragastric, intraperitoneal, and intratumoral injection compare favorably between small and large SiNPs. Improved distribution of small SiNPs was observed after intraperitoneal and intragastric injection as compared with micrometer‐size SiNPs. Sufficient clearance of nanometer‐size SiNPs using ex vivo tissue sample analysis was observed after 14 days following injection, indicating their safe use.
Conclusion
In vivo MRI of hyperpolarized small 50‐nm SiNPs is feasible with polarization levels and room‐temperature relaxation times comparable to large micrometer‐size particles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Biomedical Engineering, University and ETH Zurich, Switzerland.
- Laboratory of Inorganic Chemistry, ETH Zurich, Switzerland.
- Institute for Molecular Physical Science, ETH Zurich, Switzerland.
ORCID-Profile: Grzegorz Kwiatkowski
Förderung
- EU Horizon 2020 FETFLAG MetaboliQs
Zitieren
APA
Kwiatkowski, G., von Witte, G., Däpp, A., Kocic, J., Hattendorf, B., Ernst, M., & Kozerke, S. (2024). In vivo MRI of hyperpolarized silicon‐29 nanoparticles. Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.30244
Vancouver
Kwiatkowski G, von Witte G, Däpp A, Kocic J, Hattendorf B, Ernst M, et al. In vivo MRI of hyperpolarized silicon‐29 nanoparticles. Magnetic Resonance in Medicine. 2024. doi:10.1002/mrm.30244
BibTeX
@article{Kwiatkowski2024,
author = {Kwiatkowski, Grzegorz and von Witte, Gevin and Däpp, Alexander and Kocic, Jovana and Hattendorf, Bodo and Ernst, Matthias and Kozerke, Sebastian},
title = {In vivo MRI of hyperpolarized silicon‐29 nanoparticles},
journal = {Magnetic Resonance in Medicine},
year = {2024},
doi = {10.1002/mrm.30244}
}
EUVIMED